Finance

Lists
1733:TPE
Apex Biotechnology Corp
NT$29,05
-0,51%
(-0,15) 1D
16 Nov., 13:30:01 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1733...
Open
NT$29,30
High
NT$29,70
Low
NT$29,05
Mkt. cap
2,90 mjd
Avg. vol.
91,11 k
Volume
92,11 k
Dividend
4,48%
Quarterly dividend
NT$0,32
Ex-dividend date
09 Jun. 2026
P/E ratio
15,77
52-wk high
NT$33,10
52-wk low
NT$28,00
EPS
NT$1,84
Shares outstanding
99,69 m
No. of employees
641
Open
NT$29,30
High
NT$29,70
Low
NT$29,05
Mkt. cap
2,90 mjd
Avg. vol.
91,11 k
Volume
92,11 k
Dividend
4,48%
Quarterly dividend
NT$0,32
Ex-dividend date
09 Jun. 2026
P/E ratio
15,77
52-wk high
NT$33,10
52-wk low
NT$28,00
EPS
NT$1,84
Shares outstanding
99,69 m
No. of employees
641
News stories
From web sources and news partners
About Apex Biotechnology Corp
CEO-
Employees641
Founded1997
Headquarters-
SectorHealth Care
IndustryMedical device
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
438,99 m
519,72 m
470,65 m
428,30 m
Cost of goods sold
306,63 m
344,06 m
312,37 m
303,12 m
Cost of revenue
306,63 m
344,06 m
312,37 m
303,12 m
Research and development expenses
36,02 m
37,23 m
49,84 m
41,32 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
62,79 m
60,29 m
63,81 m
62,73 m
Operating expense
99,12 m
88,45 m
113,66 m
99,76 m
Total operating expenses
405,75 m
432,51 m
426,02 m
402,87 m
Operating income
33,24 m
87,21 m
44,63 m
25,42 m
Other non operating income
894,00 k
191,00 k
591,00 k
-4,40 m
EBT including unusual items
58,17 m
86,91 m
44,68 m
20,18 m
EBT excluding unusual items
57,52 m
90,23 m
41,45 m
20,18 m
Income tax expense
7,97 m
5,54 m
7,84 m
2,53 m
Effective tax rate
13,70%
6,38%
17,54%
12,54%
Other operating expenses
-
-
-
-
Net income
50,08 m
81,28 m
36,78 m
17,47 m
Net profit margin
11,41%
15,64%
7,81%
4,08%
Earnings per share
-
-
-
-
Interest and investment income
1,49 m
219,00 k
4,56 m
36,00 k
Interest expense
-822,00 k
-829,00 k
-804,00 k
-876,00 k
Net interest expenses
665,00 k
-610,00 k
3,75 m
-840,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
45,47 m
99,16 m
56,25 m
44,94 m
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google-programme